thymine has been researched along with Chemotherapy-Induced Febrile Neutropenia in 2 studies
Chemotherapy-Induced Febrile Neutropenia: FEVER accompanied by a significant reduction in NEUTROPHIL count associated with CHEMOTHERAPY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study assessed the efficacy and safety of biweekly trifluridine and tipiracil hydrochloride (TAS-102) with bevacizumab combination therapy for patients with metastatic colorectal cancer (mCRC)." | 5.41 | Prospective Multicenter Phase II Study of Biweekly TAS-102 and Bevacizumab for Metastatic Colorectal Cancer. ( Enomoto, M; Ishizaki, T; Kasahara, K; Katsumata, K; Kawakita, H; Matsudo, T; Mazaki, J; Nagakawa, Y; Shigoka, M; Tsuchida, A, 2021) |
| "TAS-102 (trifluridine and tipiracil hydrochloride; a novel combination oral nucleoside anti-tumor agent) has recently received regulatory approval for patients with refractory metastatic colorectal cancer (mCRC)." | 3.83 | Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study. ( Cecchini, M; Grothey, A; Hochster, HS; Kasi, PM; Kotani, D; Ohtsu, A; Ramanathan, RK; Shitara, K; Yoshino, T, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishizaki, T | 1 |
| Mazaki, J | 1 |
| Enomoto, M | 1 |
| Shigoka, M | 1 |
| Kasahara, K | 1 |
| Matsudo, T | 1 |
| Kawakita, H | 1 |
| Nagakawa, Y | 1 |
| Katsumata, K | 1 |
| Tsuchida, A | 1 |
| Kasi, PM | 1 |
| Kotani, D | 1 |
| Cecchini, M | 1 |
| Shitara, K | 1 |
| Ohtsu, A | 1 |
| Ramanathan, RK | 1 |
| Hochster, HS | 1 |
| Grothey, A | 1 |
| Yoshino, T | 1 |
1 trial available for thymine and Chemotherapy-Induced Febrile Neutropenia
| Article | Year |
|---|---|
Prospective Multicenter Phase II Study of Biweekly TAS-102 and Bevacizumab for Metastatic Colorectal Cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Chemothera | 2021 |
1 other study available for thymine and Chemotherapy-Induced Febrile Neutropenia
| Article | Year |
|---|---|
Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study.
Topics: Age Factors; Aged; Antineoplastic Agents; Chemotherapy-Induced Febrile Neutropenia; Clinical Trials, | 2016 |